Kwon Y - Search Results

1

Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction.

Hwang SY, Jeon KH, Lee HJ, Moon I, Jung S, Kim SA, Jo H, Park S, Ahn M, Kwak SY, Na Y, Kwon Y. Hwang SY, et al. Among authors: kwon y. Elife. 2024 Dec 5;13:RP97051. doi: 10.7554/eLife.97051. Elife. 2024. PMID: 39641248 Free PMC article.

2

Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.

Hwang SY, Kwak SY, Kwon Y, Lee YS, Na Y. Hwang SY, et al. Among authors: kwon y. Eur J Med Chem. 2017 Oct 20;139:892-900. doi: 10.1016/j.ejmech.2017.08.065. Epub 2017 Sep 1. Eur J Med Chem. 2017. PMID: 28869891

3

Interrupting specific hydrogen bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers.

Hwang SY, Park S, Jo H, Hee Seo S, Jeon KH, Kim S, Jung AR, Song C, Ahn M, Yeon Kwak S, Lee HJ, Uesugi M, Na Y, Kwon Y. Hwang SY, et al. Among authors: kwon y. J Adv Res. 2023 May;47:173-187. doi: 10.1016/j.jare.2022.08.003. Epub 2022 Aug 10. J Adv Res. 2023. PMID: 35963541 Free PMC article.

4

Study on the synthesis and cytotoxicity of new quinophenoxazine derivatives.

Kwon Y, Na Y. Kwon Y, et al. Chem Pharm Bull (Tokyo). 2006 Feb;54(2):248-51. doi: 10.1248/cpb.54.248. Chem Pharm Bull (Tokyo). 2006. PMID: 16462076 Free article.

5

A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.

Kim HL, Jeon KH, Jun KY, Choi Y, Kim DK, Na Y, Kwon Y. Kim HL, et al. Among authors: kwon y. Cancer Lett. 2012 Dec 1;325(1):72-9. doi: 10.1016/j.canlet.2012.06.004. Epub 2012 Jun 23. Cancer Lett. 2012. PMID: 22732416

6

Expression and purification of a soluble ESX-binding core domain of SUR2.

Jeon KH, Jun KY, Kim EY, Kwon Y. Jeon KH, et al. Among authors: kwon y. Prep Biochem Biotechnol. 2013;43(4):364-75. doi: 10.1080/10826068.2012.738273. Prep Biochem Biotechnol. 2013. PMID: 23464919

7

Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells.

Nam JM, Jeon KH, Kwon H, Lee E, Jun KY, Jin YB, Lee YS, Na Y, Kwon Y. Nam JM, et al. Among authors: kwon y, kwon h. Eur J Pharm Sci. 2013 Oct 9;50(2):181-90. doi: 10.1016/j.ejps.2013.06.014. Epub 2013 Jul 5. Eur J Pharm Sci. 2013. PMID: 23835029 Free article.

8

A series of novel terpyridine-skeleton molecule derivants inhibit tumor growth and metastasis by targeting topoisomerases.

Kwon HB, Park C, Jeon KH, Lee E, Park SE, Jun KY, Kadayat TM, Thapa P, Karki R, Na Y, Park MS, Rho SB, Lee ES, Kwon Y. Kwon HB, et al. Among authors: kwon y. J Med Chem. 2015 Feb 12;58(3):1100-22. doi: 10.1021/jm501023q. Epub 2015 Feb 2. J Med Chem. 2015. PMID: 25603122

9

Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents.

Thapa P, Kadayat TM, Park S, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES. Thapa P, et al. Among authors: kwon y. Bioorg Chem. 2016 Jun;66:145-59. doi: 10.1016/j.bioorg.2016.04.007. Epub 2016 Apr 28. Bioorg Chem. 2016. PMID: 27174797

10

Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation.

Jeon KH, Lee E, Jun KY, Eom JE, Kwak SY, Na Y, Kwon Y. Jeon KH, et al. Among authors: kwon y. Eur J Med Chem. 2016 Oct 4;121:433-444. doi: 10.1016/j.ejmech.2016.06.008. Epub 2016 Jun 9. Eur J Med Chem. 2016. PMID: 27318120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,215 results

Search Page

Filters